New York, NY, United States of America

Sergei Moussatov

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The Rockefeller University. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sergei Moussatov. Retrieved from https://idiyas.com/inventor/sergei-moussatov

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Sergei Moussatov

Introduction

Sergei Moussatov is a notable inventor based in New York, NY (US). He has made significant contributions to the field of gene therapy through his innovative work. His research focuses on developing methods that enhance the delivery of therapeutic agents using viral vectors.

Latest Patents

Moussatov holds a patent for a "Method for generating replication defective viral vectors that are helper free." This patent includes sequences capable of directing circular adeno-associated virus replication. These vectors are particularly useful in treating acute medical conditions that require rapid gene expression. The invention also provides methods for producing packaged defective viral vectors.

Career Highlights

Sergei Moussatov is affiliated with The Rockefeller University, where he conducts his research. His work has been instrumental in advancing the understanding of viral vector technology and its applications in medicine. He has a total of 1 patent to his name, showcasing his innovative contributions to the field.

Collaborations

Moussatov collaborates with Michael G Kaplitt, a fellow researcher at The Rockefeller University. Their partnership has led to advancements in the development of gene therapy techniques.

Conclusion

Sergei Moussatov's work exemplifies the intersection of innovation and medical research. His contributions to viral vector technology are paving the way for new therapeutic approaches.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…